questionText: To ask the Secretary of State for Health and Social Care, if he will publish all risk assessments conducted by his Department into the administration of puberty blockers for under 16 year-olds.
answerText: In March 2024, NHS England published a suite of documentation relating to its decision to remove gonadotrophin releasing hormone analogues as a routine treatment option in the National Health Service for children under 18 years old with gender dysphoria. ...
heading: Puberty Suppressing Hormones: Children